1. Home
  2. MPT vs STVN Comparison

MPT vs STVN Comparison

Compare MPT & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MPT

Medical Properties Trust Inc. common stock

N/A

Current Price

$5.20

Market Cap

3.1B

Sector

Real Estate

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$18.11

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPT
STVN
Founded
2003
1949
Country
United States
Italy
Employees
121
N/A
Industry
Real Estate Investment Trusts
Containers/Packaging
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MPT
STVN
Price
$5.20
$18.11
Analyst Decision
Hold
Buy
Analyst Count
1
3
Target Price
$5.00
$25.67
AVG Volume (30 Days)
4.8M
588.9K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
6.43%
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.67
Revenue Next Year
$4.91
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$4.51
$12.89
52 Week High
$6.47
$28.00

Technical Indicators

Market Signals
Indicator
MPT
STVN
Relative Strength Index (RSI) 55.59 68.18
Support Level $4.86 $13.58
Resistance Level $6.47 $26.94
Average True Range (ATR) 0.17 0.89
MACD 0.01 0.24
Stochastic Oscillator 65.84 78.14

Price Performance

Historical Comparison
MPT
STVN

About MPT Medical Properties Trust Inc. common stock

Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: